3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
1
Multi Drug Resistant Organisms
1
Meningioma
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Diabetes Mellitus
1
Brain Neoplasms
1
Interventions
Metformin
7
Surveys and Questionnaires
3
Nutrition Assessment
3
Exercise
3
Tirzepatide
2
Therapeutics
2
Tablets
2
Standard of Care
2
Specimen Handling
2
Resistance Training
2
Methods
2
Interviews as Topic
2
Glucose Tolerance Test
2
Educational Status
2
Biopsy
2
tocilizumab
1
tislelizumab
1
pembrolizumab
1
epalrestat
1
donafenib
1
amlodipine, atorvastatin drug combination
1
Verapamil
1
Urine Specimen Collection
1
Testosterone
1
Secretin
1
Second Harmonic Generation Microscopy
1
Risk Assessment
1
Remote Consultation
1
Preventive Health Services
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Diabetes Mellitus
×
Verapamil
×
Clear all
NCT04233034
2024-11-27
CLVer
Jaeb Center for Health Research
Phase 3
Completed
113 enrolled
42 charts